| CMPX Stock | | | USD 1.50 0.01 0.67% |
Compass Therapeutics financial indicator trend analysis is way more than just evaluating Compass Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Compass Therapeutics is a good investment. Please check the relationship between Compass Therapeutics Cost Of Revenue and its Other Operating Expenses accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Compass Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Compass Stock please use our
How to Invest in Compass Therapeutics guide.
Cost Of Revenue vs Other Operating Expenses
Cost Of Revenue vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Compass Therapeutics Cost Of Revenue account and
Other Operating Expenses. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Compass Therapeutics' Cost Of Revenue and Other Operating Expenses is -0.32. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Compass Therapeutics, assuming nothing else is changed. The correlation between historical values of Compass Therapeutics' Cost Of Revenue and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Compass Therapeutics are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Cost Of Revenue i.e., Compass Therapeutics' Cost Of Revenue and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | -0.32 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Cost Of Revenue
Cost of Revenue is found on Compass Therapeutics income statement and represents the costs associated with goods and services Compass Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Compass Therapeutics. It is also known as Compass Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most indicators from Compass Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Compass Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Compass Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in american community survey.
For more information on how to buy Compass Stock please use our
How to Invest in Compass Therapeutics guide.At this time, Compass Therapeutics'
Tax Provision is fairly stable compared to the past year.
Selling General Administrative is likely to rise to about 12.9
M in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 3
M in 2024.
Compass Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Compass Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Compass Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Compass Stock Analysis
When running Compass Therapeutics' price analysis, check to
measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.